.jpg)
.png)
All
Definition of Metabolic Syndrome Metabolic syndrome is considered a "multiplex" cardiovascular risk factor, in that each component of the cluster of abnormalities is a risk factor in its own right. Metabolic syndrome is recognized clinically by the findings of abdominal obesity,... more
The National Lipid Association (NLA) endorses the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, published by the American College of Cardiology on April 1 in the... more
Background In the United States, hypertension accounts for more cardiovascular disease (CVD) deaths than any other modifiable CVD risk factor and is second only to cigarette smoking as a preventable cause of death. In 2010, high blood pressure (BP) was the leading cause of death and disability... more
Visit NLA's E-Poster Hall to view this year's submitted abstracts for the 2014 Annual Scientific Sessions Meeting. The NLA E-Poster Hall includes a vast array of topics in 16 categories, including clinical applications of biomarkers, epidemiology of cardiovascular disease, management of... more
2026 Fall Clinical Lipid Update The go-to weekend for practical, evidence-based lipid care – built for clinicians who want what’s next and what works Monday morning. OCTOBER 2 – 4, 2026 | JW MARRIOTT ORLANDO BONNET CREEK | ORLANDO, FL | IN-PERSON OR VIRTUAL... more
Interviewed by NLA Membership Manager Brandi Rawls. What triggered your interest in medicine? Most of us who go into medical fields are natural rescuers. As a little girl, I filled up drawers in my house for broken popsicle sticks, rocks and other inanimate objects that looked broken or old... more
As your new president I extend my warm greetings. Some introductions first. I am a clinical pharmacist working for the Department of Veterans Affairs at Buffalo, New York. My Lipid Clinic Practice is now 29-years-old, and I have been with NELA for over 15 of those years. ... more
In February, the NLA visited New Orleans, Louisiana for three days of important clinical lipid updates. Here is a small selection of what you missed.